Beleave Provides Upd
Beleave Provides Update on Manitoba Retail Licensing Agreement
01. März 2018 16:30 ET | Beleave Inc.
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE); (OTCQX:BLEVF) would like to provide an update with regard to recent retail licensing grants in the...
Beleave Receives Not
Beleave Receives Notification of Pre-Sale Inspection Date
31. Januar 2018 07:35 ET | Beleave Inc.
TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE)(OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that the...
Beleave Signs Letter
Beleave Signs Letter of Intent with Seven Oaks Cannabis
03. Januar 2018 07:25 ET | Beleave Inc.
TORONTO, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has signed a letter of intent with Seven Oaks Cannabis Inc....
Beleave Provides Bus
Beleave Provides Business Update
14. Dezember 2017 20:07 ET | Beleave Inc.
TORONTO, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that, upon the...
Beleave Signs Brand
Beleave Signs Brand Licensing Agreement with Kevin Smith & Jason Mewes
07. Dezember 2017 07:45 ET | Beleave Inc.
TORONTO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has entered into a Brand Licensing Agreement with Kevin...
Beleave Closes $9.95
Beleave Closes $9.95 Million Non-Brokered Private Placement of Units
05. Dezember 2017 18:37 ET | Beleave Inc.
TORONTO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce the completion of a non-brokered private placement (the...
Beleave Receives Lic
Beleave Receives License to Produce Cannabis Oils from Health Canada
04. Dezember 2017 18:18 ET | Beleave Inc.
TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE)( OTCQX:BLEVF) is pleased to announce it has been granted a license by Health Canada to begin commercial...
Beleave Announces $5
Beleave Announces $5 Million Non-Brokered Private Placement of Units
20. November 2017 07:25 ET | Beleave Inc.
TORONTO, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce its intention to complete a non-brokered private placement (the...
Beleave Supports Rec
Beleave Supports Recent Council Decision and Continues Expansion Uninterrupted
10. November 2017 07:30 ET | Beleave Inc.
TORONTO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (“Beleave”) (CSE:BE) (OTCQX:BLEVF) strongly supports The City of Hamilton council’s decision to turn down the motion for any new restrictions...
Beleave and Dr. Mich
Beleave and Dr. Michael Rogers Begin Research in Cannabis Food and Drug Delivery
24. Oktober 2017 07:30 ET | Beleave Inc.
TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (“Beleave”) (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it will begin a research program with Dr. Michael Rogers to develop and...